LOCAL-CAR Hydrogel-nanoparticle delivery platform for LOCALized CAR-M immunotherapy
- Coordinator
- Technische Universiteit Eindhoven, Netherlands
- Runs
- 1 November 2026 to 30 April 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 2 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101334969
What the project is doing
In the project's own words, from its summary on CORDIS.
LOCAL-CAR is a Proof-of-Concept project aimed at validating a modular hydrogel-based platform for localized mRNA immunotherapy, targeting peritoneal tumor burden in ovarian and colorectal cancer models. Building on ERC-funded technologies – ABGel and aNP-mRNA – the project integrates these into a single ABGel-mRNA system for sustained intraperitoneal immunotherapy. The platform will generate HER2-CAR-expressing macrophages (CAR-M) directly within the peritoneal cavity, enabling local anti-HER2-tumor activity.
The project objectives are: (1) optimize ABGel-mRNA formulations encoding HER2-CAR constructs and screen their ability to generate functional CAR-M in vitro; (2) evaluate in vivo CAR‑M induction and therapeutic efficacy in mouse ovarian and colorectal cancer models; (3) develop IP strategy and expand patent portfolio; (4) conduct market analysis and engage stakeholders in the emerging in vivo CAR therapy landscape; and (5) disseminate findings and build strategic partnerships.
Co-applicant BioTrip supports IP management, regulatory strategy, and commercialization. LOCAL-CAR addresses a critical unmet need in oncology and offers a scalable, biocompatible solution with broad translational potential in immunotherapy, autoimmune diseases, and vaccination.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technische Universiteit Eindhoven | Eindhoven | Netherlands | Coordinator |
| Bio-Trip B.v. | Bosch En Duin | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI